Dexamethasone Treatment Options in United Kingdom

A collection of 187 research studies where Dexamethasone is the interventional treatment. These studies are located in the United Kingdom . Dexamethasone is used for conditions such as Multiple Myeloma, Postoperative Pain and Lymphoma.

Home

United Kingdom

All Treatments

Dexamethasone

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

NCT03201965

Completed

The purpose of this study is to evaluate the efficacy and safety of daratumumab plus cyclophosphamide, bortezomib and dexamethasone (CyBorD) compared with CyBorD alone in treatment of newly diagnosed amyloid light chain (AL) amyloidosis participants.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/22/2025

Locations: Mayo Clinic Arizona, Phoenix, Arizona +139 locations

Mayo Clinic Arizona, Phoenix, Arizona

City of Hope, Duarte, California

University of California San Francisco, San Francisco, California

Stanford University, Stanford, California

University of Colorado, Aurora, Colorado

Colorado Blood Cancer Institute, Denver, Colorado

Mayo Clinic, Jacksonville, Florida

Winship Cancer Institute Emory University, Atlanta, Georgia

University of Maryland, Baltimore, Maryland

Tufts Medical Center, Boston, Massachusetts

Boston University Medical Center, Boston, Massachusetts

Dana Farber Cancer Institute, Boston, Massachusetts

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Mayo Clinic Rochester, Rochester, Minnesota

Washington University School Of Medicine, Saint Louis, Missouri

Columbia University Medical Center, New York, New York

Weill Cornell Medical College, New York, New York

University of Rochester Medical Center, Rochester, New York

Levine Cancer Institute, Charlotte, North Carolina

Wake Forest University Health Sciences - Cardiovascular Medicine, Winston-Salem, North Carolina

Cleveland Clinic, Cleveland, Ohio

The Ohio State University, Columbus, Ohio

Oregon Health And Science University, Portland, Oregon

University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Sarah Cannon Research Institute, Nashville, Tennessee

Vanderbilt University Medical Center, Nashville, Tennessee

University of Texas, MD Anderson Cancer Center, Houston, Texas

Huntsman Cancer Institute, Salt Lake City, Utah

Seattle Cancer Care Alliance, Seattle, Washington

Box Hill Hospital, Box Hill, Not set

Sir Charles Gairdner Hospital, Nedlands, Not set

Westmead Hospital, Westmead, Not set

Princess Alexandra Hospital, Woolloongabba, Not set

Institut Jules Bordet, Anderlecht, Not set

UZ Gent, Gent, Not set

Az Groeninge, Kortrijk, Not set

Universitair Ziekenhuis Leuven, Leuven, Not set

Hospital das Clinicas de Porto Alegre, Porto Alegre, Not set

Sociedade Pernambucana de Combate ao Cancer, Recife, Not set

Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI), Rio de Janeiro, Not set

Hospital Sao Rafael, Salvador, Not set

Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto Hospital de Base, Sao Jose do Rio Preto, Not set

Instituto de Assistencia Medica ao Servidor Publico Estadual IAMSPE, Sao Paulo, Not set

Clinica Sao Germano, São Paulo, Not set

Hospital Das Clinicas Da Faculdade De Medicina Da USP, São Paulo, Not set

Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta

Alberta Health Services, Edmonton, Alberta

Vancouver General Hospital, Vancouver, British Columbia

London Health Sciences Center, London, Ontario

University Health Network UHN Princess Margaret Cancer Centre, Toronto, Ontario

McGill University Health Centre, Montreal, Quebec

Peking University First Hospital, Beijing, Not set

Peking University People s Hospital, Beijing, Not set

First affiliated Hospital of Zhejiang University, Hangzhou, Not set

Ruijin Hospital Shanghai Jiao Tong University, Shanghai, Not set

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Not set

Aarhus University Hospital, Aarhus N, Not set

Dep. of Hematology, Rigshospitalet, Copenhagen, Not set

Odense Universitets Hospital, Odense, Not set

CHU Dijon, Dijon, Not set

Hopital Claude Huriez, Lille cedex, Not set

CHU de Limoges - Fédération Hépatologie, Limoges, Not set

Institut Paoli Calmettes, Marseille, Not set

Chu Hotel Dieu, Nantes cedex 01, Not set

Hopital Saint Louis, PARIS cedex 10, Not set

Centre hospitalier Lyon-Sud, Pierre - Bénite cedex, Not set

CHU De Poitiers, Poitiers, Not set

CHU Rangueil, Toulouse, Not set

CHU Bretonneau, Tours cedex, Not set

CHU de Nancy_ Hopital Brabois, Vandoeuvre les Nancy, Not set

Charite Campus Benjamin Franklin, Berlin, Not set

Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Not set

Universitatsklinikum Essen, Essen, Not set

HOPA-Hämatologisch-Onkologische Praxis Altona MVZ GmbH, Hamburg, Not set

Universitaetsklinikum Heidelberg Medizinische Klinik V, Heidelberg, Not set

Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II,, Tübingen, Not set

Universitätsklinikum Würzburg Med. Klinik U. Poliklinik Ii, Würzburg, Not set

Alexandra General Hospital of Athens, Athens, Not set

University General Hospital of Rio, Patra, Not set

Semmelweis Egyetem I.Belgyogyaszati Klinika, Budapest, Not set

Del Pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet Szent Laszlo Telephely, Budapest, Not set

Carmel Hospital, Haifa, Not set

Hadassah Medical Center, Jerusalem, Not set

Sheba Medical Center, Ramat-Gan, Not set

Sourasky Medical Center, Tel-Aviv, Not set

Assaf Ha'Rofeh Medical Center, Zerifin, Not set

Policlinico di Bari, Bari, Not set

Istituto di Ematologia Seràgnoli azienda ospedaliera univeristaria Policlinico S.Orsola-Malpighi, Bologna, Not set

Casa di Cura La Maddalena, Palermo, Not set

Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Not set

Dipartimento Di Biotecnologie Cellulari Ed Ematologia-Università ''La Sapienza'',Policlinico Umberto I, Roma, Not set

A.O.U. Città della Salute e della Scienza, Torino, Not set

Fukushima Medical University Hospital, Fukushima, Not set

Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Not set

Teine Keijinkai Hospital, Hokkaido, Not set

Kanazawa University Hospital, Kanazawa, Not set

Kumamoto University Hospital, Kumamoto-City, Not set

Kyoto Kuramaguchi Medical Center, Kyoto, Not set

Shinshu University Hospital, Matsumoto, Not set

Matsuyama Red Cross Hospital, Matsuyama, Not set

Nagoya City University Hospital, Nagoya, Not set

National Hospital Organization Okayama Medical Center, Okayama, Not set

Japanese Red Cross Medical Center, Shibuya, Not set

Tokushima University Hospital, Tokushima, Not set

Pusan National University Hospital, Busan, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System, Seoul, Not set

Samsung Medical Center, Seoul, Not set

The Catholic University of Korea Seoul St Marys Hospital, Seoul, Not set

Centro de Investigación Farmacéutica Especializada, Guadalajara, Not set

Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey, Not set

Haga ziekenhuis, Den Haag, Not set

UMCG, Groningen, Not set

Erasmus MC, Rotterdam, Not set

UMC Utrecht, Utrecht, Not set

Maxima Medisch Centrum, Veldhoven, Not set

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich, Chorzow, Not set

SKPP UM w Poznaniu, Poznan, Not set

Instytut Hematologii i Transfuzjologii, Warszawa, Not set

Inst. Cat. D'Oncologia-Badalona, Badalona, Not set

Hosp Univ Vall D Hebron, Barcelona, Not set

Hosp Clinic de Barcelona, Barcelona, Not set

Hosp. Univ. Ramon Y Cajal, Madrid, Not set

Hosp Univ Fund Jimenez Diaz, Madrid, Not set

Hosp. Univ. 12 de Octubre, Madrid, Not set

Clinica Univ. de Navarra, Pamplona, Not set

Hosp Clinico Univ de Salamanca, Salamanca, Not set

Hosp. Univ. de Canarias, San Cristóbal de La Laguna, Not set

Hosp. Univ. Dr. Peset, Valencia, Not set

South Elvsborg Hospital, Boras, Not set

Skanes universitetssjukhus, Lund, Not set

Ankara Universitesi Tip Fakultesi Cebeci Hastanesi, Ankara, Not set

Akdeniz University Medical Faculty, Antalya, Not set

Ondokuz Mayis Universitesi Tip Fakultesiy, Atakum, Not set

Istanbul University Istanbul Medical Faculty, Istanbul, Not set

Dokuz Eylul Universitesi Tip Fakultesi, Izmir, Not set

Erciyes University Medical Faculty, Talas, Not set

University Hospitals Birmingham NHS Trust,, Birmingham, Not set

University College Hospital, London, Not set

Conditions: Amyloidosis

Learn More ›

Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT02303821

Completed

The purpose of Phase 1b of this study is to: * Asses the safety, tolerability and activity of carfilzomib, alone and in combination with induction chemotherapy, in children with relapsed or refractory acute lymphoblastic leukemia (ALL). * Determine the maximum tolerated dose (MTD) and to recommend a phase 2 dose of carfilzomib in combination with induction chemotherapy. The purpose of Phase 2 of this study is to compare the rate of complete remission (CR) of carfilzomib in combination with vin... Read More

Gender:

ALL

Ages:

Between 1 month and 21 years

Trial Updated:

05/16/2025

Locations: University of California San Francisco Benioff Childrens Hospital Oakland, Oakland, California +121 locations

University of California San Francisco Benioff Childrens Hospital Oakland, Oakland, California

Childrens Hospital of Orange County, Orange, California

Childrens Hospital Colorado, Aurora, Colorado

Childrens Healthcare of Atlanta, Egleston, Atlanta, Georgia

Lurie Childrens Hospital of Chicago, Chicago, Illinois

The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, Maryland

Childrens Hospital and Clinics of Minnesota, Minneapolis, Minnesota

Childrens Mercy Hospital, Kansas City, Missouri

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

Childrens Hospital of New York Presbyterian, New York, New York

Levine Childrens Hospital at Carolinas Medical Center d/b/a Atrium Health, Charlotte, North Carolina

Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio

The Cleveland Clinic Foundation, Cleveland, Ohio

Nationwide Childrens Hospital, Columbus, Ohio

Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania

Saint Judes Childrens Research Hospital, Memphis, Tennessee

Childrens Medical Center, Dallas, Texas

Texas Childrens Hospital West Tower, Houston, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

University of Utah Medical Center Primary Childrens Medical Center, Salt Lake City, Utah

West Virginia University Medicine Childrens, Morgantown, West Virginia

Medical College of Wisconsin, Milwaukee, Wisconsin

Hospital Aleman, Ciudad Autonoma de Buenos Aires, Buenos Aires

Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aires, Buenos Aires

Hospital Universitario Austral, Pilar, Buenos Aires

Sydney Childrens Hospital, Randwick, New South Wales

The Childrens Hospital at Westmead, Westmead, New South Wales

Queensland Childrens Hospital, South Brisbane, Queensland

The Royal Childrens Hospital, Parkville, Victoria

Perth Childrens Hospital, Nedlands, Western Australia

St Anna Kinderspital, Wien, Not set

Hospital São Rafael - IDOR, Salvador, Bahia

Hospital da Crianca de Brasília, Brasília, Distrito Federal

Liga Paranaense do Combate ao Cancer - Hospital Erasto Gaertner, Curitba, Paraná

Hospital Pequeno Principe, Curitiba, Paraná

Instituto de Medicina Integral Professor Fernando Figueira, Recife, Pernambuco

Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul

Hospital da Crianca Santo Antonio Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul

Fundacao Pio 12 Hospital de Amor de Barretos, Barretos, São Paulo

Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo, Ribeirao Preto, São Paulo

Itaci Instituto de Tratamento do Cancer Infantil, Sao Paulo, São Paulo

Beneficencia Portuguesa de Sao Paulo, São Paulo, Not set

University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna-ISUL EAD, Sofia, Not set

Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec

Hospital Luis Calvo Mackenna, Santiago de Chile, Not set

Hospital Roberto del Rio, Santiago, Not set

Sociedad de Oncologia y Hematologia del Cesar, Valledupar, Cesar

Clinica Imbanaco S.A.S, Cali, Valle Del Cauca

Fakultni nemocnice Brno, Brno, Not set

University Hospital Rigshospitalet, Kobenhavn O, Not set

Centre Hospitalier Universitaire de Bordeaux - Hopital Pellegrin, Bordeaux Cedex, Not set

Centre Hospitalier Regional Universitaire de Lille, Lille, Not set

Hopital Armand Trousseau, Paris, Not set

Hopital Robert Debre, Paris, Not set

Centre Hospitalier Universitaire de Toulouse - Hopital des enfants, Toulouse Cedex 9, Not set

Centre Hospitalier Universitaire de Nancy - Hopital Enfants de Brabois, Vandoeuvre les Nancy Cedex, Not set

Agia Sofia Children Hospital, Athens, Not set

Agia Sofia Children Hospital, Goudi, Not set

General Children Hospital Panagioti and Aglaias Kyriakou, Goudi, Not set

General University Hospital of Patras Panagia i Voithia, Patra, Not set

Ippokrateio General Hospital of Thessaloniki, Thessaloniki, Not set

Hong Kong Childrens Hospital, Kowloon Bay, Not set

Sheba Medical Center, Tel Hashomer, Not set

Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Not set

Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ospedaliero G Rodolico, Catania, Not set

IRCCS Istituto Giannina Gaslini, Genova, Not set

Fondazione IRCCS San Gerardo dei Tintori, Monza (MB), Not set

Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Napoli, Not set

Azienda Ospedaliera di Padova, Padova, Not set

Fondazione IRCCS Policlinico San Matteo, Pavia, Not set

IRCCS Ospedale Pediatrico Bambino Gesu, Roma, Not set

Azienda Ospedaliera Citta della Salute e della Scienza Torino Ospedale Infantile Regina Margherita, Torino, Not set

Seoul National University Hospital, Seoul, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Pusan National University Yangsan Hospital, Yangsan-si, Gyeongsangnam-do, Not set

BRCR Global Mexico, Mexico, Distrito Federal

Instituto Nacional de Pediatria, Mexico, Distrito Federal

BRCR Global Mexico, Guadalajara, Jalisco

BRCR Global Mexico, Puebla, Not set

Prinses Maxima Centrum voor Kinderoncologie, Utrecht, Not set

Oslo Universitetssykehus Rikshospitalet, Oslo, Not set

Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow, Not set

CSK Uniwersytetu Medycznego w Lodzi Uniwersyteckie Centrum Pediatrii im Marii Konopnickiej, Lodz, Not set

Uniwersytecki szpital dzieciecy, Lublin, Not set

Uck wum dzieciecy szpital kliniczny im jozefa polikarpa brudzinskiego, Warszawa, Not set

Uniwersytecki Szpital Kliniczny im Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw, Not set

SPSK nr 1 im Prof Stanislawa Szyszko Slaskiego Uniwersytetu Medycznego w Katowicach, Zabrze, Not set

Centro Hospitalar Universitario de Coimbra, Coimbra, Not set

Instituto Portugues de Oncologia de Lisboa Francisco Gentil, EPE, Lisboa, Not set

Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE, Porto, Not set

Institutul Clinic Fundeni, Bucharest, Not set

Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca, Cluj Napoca, Not set

Spitalul Clinic de Urgenta pentru Copii Louis Turcanu Timisoara, Timisoara, Not set

FSBI N N Blokhin Russian Oncology Research Center Ministry of Health of Russian Federation, Moscow, Not set

FSBI FSCC of pediatric hematology, oncology and immunology n a Dmitry Rogachev, Moscow, Not set

SBEI of HPE Saint Petersburg State Medical University na academic I P Pavlov of MoH of RF, Saint Petersburg, Not set

King Fahad Medical City, Riyadh, Not set

National University Hospital, Singapore, Not set

KK Womens and Childrens Hospital, Singapore, Not set

Chris Hani Baragwanath Hospital, Johannesburg, Not set

Hospital Sant Joan de Deu, Esplugues de Llobregat, Cataluña

Hospital Universitario Infantil Niño Jesus, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Karolinska Universitetssjukhuset Solna, Solna, Not set

National Taiwan University Hospital, Taipei, Not set

Mackay Memorial Hospital Taipei Branch, Taipei, Not set

Linkou Chang Gung Memorial Hospital, Taoyuan, Not set

King Chulalongkorn Memorial Hospital, Bangkok, Not set

Phramongkutklao Hospital, Bangkok, Not set

Ramathibodi Hospital, Bangkok, Not set

Siriraj Hospital, Bangkok, Not set

Acibadem Adana Hastanesi, Adana, Not set

Ankara Universitesi Tip Fakultesi Hastanesi, Ankara, Not set

Ankara Bilkent Sehir Hastanesi, Ankara, Not set

Medical Park Antalya Hastanesi, Antalya, Not set

Bursa Uludag Universitesi Tip Fakultesi, Bursa, Not set

Medical Park Bahcelievler Hastanesi, Istanbul, Not set

Medipol Mega Universite Hastanesi, Istanbul, Not set

Ege Universitesi Tip Fakultesi, Izmir, Not set

Erciyes Universitesi Tip Fakultesi Mustafa Eraslan ve Fevzi Mercan Cocuk Hastanesi, Kayseri, Not set

The Royal Marsden NHS Foundation Trust, Sutton, Not set

Conditions: Acute Lymphoblastic Leukemia (ALL)

Learn More ›

A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

NCT05738486

Active Not Recruiting

This study will investigate different donanemab dosing regimens and their effect on the frequency and severity of ARIA-E in adults with early symptomatic Alzheimer's disease (AD) and explore participant characteristics that might predict risk of ARIA. Approximately 300 additional participants will be enrolled per addendum. The study will last approximately 91 weeks and include up to 26 visits in the main study.

Gender:

ALL

Ages:

Between 60 years and 85 years

Trial Updated:

05/07/2025

Locations: MD First Research - Chandler, Chandler, Arizona +48 locations

MD First Research - Chandler, Chandler, Arizona

Irvine Clinical Research, Irvine, California

Healthy Brain Clinic, Long Beach, California

California Neuroscience Research Medical Group, Inc., Sherman Oaks, California

JEM Research Institute, Atlantis, Florida

VIN-Julie Schwartzbard, Aventura, Florida

Excel Medical Clinical Trials, Boca Raton, Florida

K2 Medical Research, Clermont, Florida

Brain Matters Research, Delray Beach, Florida

Neuropsychiatric Research Center of Southwest Florida, Fort Myers, Florida

Finlay Medical Research, Greenacres City, Florida

Infinity Clinical Research, LLC, Hollywood, Florida

Jacksonville Center for Clinical Research, Jacksonville, Florida

ClinCloud - Maitland, Maitland, Florida

K2 Medical Research, Maitland, Florida

ClinCloud - Viera, Melbourne, Florida

Suncoast Clinical Research, Inc., New Port Richey, Florida

Renstar Medical Research, Ocala, Florida

Charter Research - Winter Park, Orlando, Florida

Progressive Medical Research, Port Orange, Florida

Alzheimer's Research and Treatment Center, Stuart, Florida

K2 Medical Research - Tampa, Tampa, Florida

K2 Summit Research, The Villages, Florida

Charter Research - Lady Lake, The Villages, Florida

Alzheimer's Research and Treatment Center, Wellington, Florida

Palm Beach Neurology, West Palm Beach, Florida

Conquest Research, Winter Park, Florida

Columbus Memory Center, LLC, Columbus, Georgia

CenExel iResearch, LLC, Decatur, Georgia

Center for Advanced Research & Education, Gainesville, Georgia

CenExel iResearch, LLC, Savannah, Georgia

MedVadis Research Corporation, Waltham, Massachusetts

Adams Clinical, Watertown, Massachusetts

QUEST Research Institute, Farmington Hills, Michigan

The Cognitive and Research Center of New Jersey, Springfield, New Jersey

Butler Hospital, Providence, Rhode Island

Neurology Clinic, P.C., Cordova, Tennessee

Gadolin Research, Beaumont, Texas

Kerwin Medical Center, Dallas, Texas

The University of Texas Health Science Center at Houston, Houston, Texas

Re:Cognition Health, Fairfax, Virginia

Northwest Clinical Research Center, Bellevue, Washington

Universal Research Group, Tacoma, Washington

Re:Cognition Health - Bristol, Bristol, Bristol, City Of

Re:Cognition Health - Winchester, Winchester, Hampshire

Re:Cognition Health - London, London, London, City Of

Re:Cognition Health Guildford, Guildford, Reading

Re:Cognition Health - Birmingham, Birmingham, Not set

Re:Cognition Health - Plymouth, Plymouth, Not set

Conditions: Alzheimer's Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders

Learn More ›

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

NCT04068597

Recruiting

A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 (inobrodib) in patients with Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukaemia or High Risk Myelodysplastic syndrome.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/07/2025

Locations: Community Health Network, Indianapolis, Indiana +21 locations

Conditions: Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma, Higher-risk Myelodysplastic Syndrome, Peripheral T Cell Lymphoma

Learn More ›

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

NCT03158688

Completed

Compare carfizomib, dexamethasone, and daratumumab (KdD) to Carfilzomib and dexamethasone (Kd) in terms of progression free survival (PFS) in participants with multiple myeloma who have relapsed after 1 to 3 prior therapies.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/01/2025

Locations: Lynn Cancer Center Boca Raton Regional Hospital, Lynn Cancer Institute, Boca Raton, Florida +112 locations

Lynn Cancer Center Boca Raton Regional Hospital, Lynn Cancer Institute, Boca Raton, Florida

Emory University Winship Cancer Institute, Atlanta, Georgia

University of Chicago Medical Center - Multiple Myeloma Research Consortium, Chicago, Illinois

Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana

Hattiesburg Clinic Hematology/Oncology, Hattiesburg, Mississippi

Hackensack University Medical Center, Hackensack, New Jersey

New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York

Levine Cancer Institute, Charlotte, North Carolina

Gabrail Cancer Center, LLC, Dover, Ohio

Charleston Oncology, Charleston, South Carolina

Baylor Charles A Sammons Cancer Center at Dallas, Dallas, Texas

Liverpool Hospital, Liverpool, New South Wales

St Vincents Hospital Sydney, St Leonards, New South Wales

Westmead Hospital, Westmead, New South Wales

Royal Brisbane and Womens Hospital, Herston, Queensland

Princess Alexandra Hospital, Woolloongabba, Queensland

Royal Adelaide Hospital, Adelaide, South Australia

Epworth Healthcare, East Melbourne, Victoria

St Vincents Hospital Melbourne, Fitzroy, VIC, Victoria

Barwon Health, University Hospital Geelong, Geelong, Victoria

The Alfred Hospital, Melbourne, Victoria

Medizinische Universitaet Graz, Graz, Not set

Landeskrankenhaus Salzburg, Salzburg, Not set

Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerpen, Not set

Universitair Ziekenhuis Brussel, Brussel, Not set

Grand HÃ´pital de Charleroi, Charleroi, Not set

Universitair Ziekenhuis Gent, Gent, Not set

Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven, Not set

University Multiprofile Hospital for Active Treatment Sveti Georgi EAD, Plovdiv, Not set

University Multiprofile Hospital for Active Treatment Sveti Ivan Rilski EAD, Sofia, Not set

Specialized Hospital for Active Treatment of Hematology Diseases EAD, Sofia, Not set

Tom Baker Cancer Centre, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

Ottawa Hospital Research Institute, Ottawa, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Hopital Maisonneuve-Rosemont, Montreal, Quebec

Fakultni nemocnice Brno, Brno, Not set

Fakultni nemocnice Hradec Kralove, Hradec Kralove, Not set

Fakultni nemocnice Ostrava, Ostrava-Poruba, Not set

Fakultni nemocnice Plzen, Plzen, Not set

Vseobecna fakultni nemocnice v Praze, Praha 2, Not set

Centre Hospitalier DÃ©partemental les Oudairies, La Roche Sur Yon Cedex 9, Not set

Centre Hospitalier de Versailles - Hopital Andre Mignot, Le Chesnay cedex, Not set

Centre Hospitalier RÃ©gional Universitaire de Lille - HÃ´pital Claude Huriez, Lille Cedex, Not set

Centre Hospitalier Universitaire de Nantes, Nantes Cedex 1, Not set

Centre Hospitalier Universitaire de Bordeaux - Hopital Haut Leveque, Pessac Cedex, Not set

Centre Hospitalier Lyon Sud, Pierre-Benite cedex, Not set

Centre Hospitalier Universitaire de Poitiers - Hopital la Miletrie, Poitiers Cedex, Not set

Centre Hospitalier Universitaire de Nancy - Hopital de Brabois, Vandoeuvre les Nancy Cedex, Not set

General Hospital Evangelismos, Athens, Not set

Alexandra Hospital, Athens, Not set

General University Hospital of Patras Panagia i Voithia, Patra, Not set

Theagenion Cancer Hospital of Thessaloniki, Thessaloniki, Not set

Bekes Megyei Kozponti Korhaz Dr Rethy Pal Tagkorhaz, Bekescsaba, Not set

Semmelweis Egyetem, Budapest, Not set

Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest, Not set

Debreceni Egyetem Klinikai Kozpont, Debrecen, Not set

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, Szeged, Not set

Nagoya City University Hospital, Nagoya-shi, Aichi

Toyohashi Municipal Hospital, Toyohashi-shi, Aichi

Tesshokai Kameda General Hospital, Kamogawa-shi, Chiba

National Hospital Organization Kyushu Cancer Center, Fukuoka-shi, Fukuoka

Kyushu University Hospital, Fukuoka-shi, Fukuoka

Ogaki Municipal Hospital, Ogaki-shi, Gifu

Gunma University Hospital, Maebashi-shi, Gunma

National Hospital Organization Shibukawa Medical Center, Shibukawa-shi, Gunma

University Hospital Kyoto Prefectural University of Medicine, Kyoto-shi, Kyoto

Niigata Cancer Center Hospital, Niigata-shi, Niigata

National Hospital Organization Okayama Medical Center, Okayama-shi, Okayama

Osaka University Hospital, Suita-shi, Osaka

Saitama Medical Center, Kawagoe-shi, Saitama

Tochigi Cancer Center, Utsunomiya-shi, Tochigi

Tokushima Prefectural Central Hospital, Tokushima-shi, Tokushima

Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo

Japanese Red Cross Medical Center, Shibuya-ku, Tokyo

National Cancer Center, Goyang-si, Gyeonggi-do, Not set

Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System, Seoul, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

The Catholic University of Korea Seoul St Marys Hospital, Seoul, Not set

InterHem, Bialystok, Not set

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich w Chorzowie, Chorzow, Not set

Centrum Onkologii Ziemi Lubelskiej im Swietego Jana z Dukli, Lublin, Not set

Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im K Marcinkowskiego w Poznaniu, Poznan, Not set

Instytut Hematologii i Transfuzjologii, Warszawa, Not set

Uniwersytecki Szpital Kliniczny im Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw, Not set

Policlinica de Diagnostic Rapid, Brasov, Not set

Fundeni Clinical Institute, Bucharest, Not set

Coltea Clinical Hospital, Bucharest, Not set

Spitalul Clinic Colentina, Bucuresti, Not set

Bucharest Emergency University Hospital, Bucuresti, Not set

Profesor Dr Ion Chiricuta Institut of Oncology, Cluj-Napoca, Not set

Spitalul Clinic Municipal Filantropia Craiova, Craiova, Not set

SBHI of Nizhny Novgorod region Regional Clinical Hospital of Nizhny Novgorod na N A Semashko, Nizhny Novgorod, Not set

SBHI of Republic of Karelia Republic Hosiptal n a V A Baranov, Petrozavodsk, Not set

State Budget Educational Institution of High Professional Skills Samara State Medical University, Samara, Not set

Clinic of professional pathology and hematology, Saratov, Not set

Hospital Clinico Universitario de Salamanca, Salamanca, Castilla LeÃ³n

Hospital Universitari Germans Trias i Pujol, Badalona, CataluÃ±a

Hospital Clinic i Provincial de Barcelona, Barcelona, CataluÃ±a

Clinica Universidad de Navarra, Pamplona, Navarra

Hospital Universitario 12 de Octubre, Madrid, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Hacettepe Universitesi Tip Fakultesi, Ankara, Not set

Ankara Universitesi Tip Fakultesi Cebeci Hastanesi, Ankara, Not set

Ege University Faculty of Medicine, Izmir, Not set

Ondokuz Mayis Universitesi Tip Fakultesi, Samsun, Not set

St James University Hospital, Leeds, Not set

University College London Hospital, London, Not set

Christie Hospital, Manchester, Not set

Conditions: Relapsed Multiple Myeloma, Refractory Multiple Myeloma

Learn More ›

A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens

NCT03412565

Completed

The purpose of this study is to evaluate the clinical benefit of subcutaneous (SC) daratumumab administered in combination with standard multiple myeloma (MM) regimens in participants with MM as measured by overall response rate (ORR) or very good partial response (VGPR) or better rate.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/25/2025

Locations: Cancer Center of Central Connecticut - Southington, Southington, Connecticut +63 locations

Cancer Center of Central Connecticut - Southington, Southington, Connecticut

Mayo Clinic in Florida, Jacksonville, Florida

UF Health Cancer Center at Orlando Health, Orlando, Florida

Karmonos Cancer Institute, Detroit, Michigan

Providence Cancer Center, Southfield, Michigan

Billings Clinic, Billings, Montana

Nebraska Hematology and Oncology, Lincoln, Nebraska

Southeast Nebraska Cancer Center, Lincoln, Nebraska

Nebraska Cancer Specialists, Omaha, Nebraska

San Juan Oncology Associates, Farmington, New Mexico

NYU Winthrop, Mineola, New York

Mt. Sinai School of Medicine, New York, New York

Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center, Winston-Salem, North Carolina

Avera Medical Group - Oncology & Hematology, Sioux Falls, South Dakota

Utah Cancer Specialists, Salt Lake City, Utah

University of Virginia Cancer Center - Emily Couric Clinical Cancer Center - Women's Oncology Clinic, Charlottesville, Virginia

Liga Norte Riograndense Contra O Cancer, Natal, Not set

Associacao Hospitalar Beneficente Sao Vicente de Paulo - Hospital Sao Vicente de Paulo, Passo Fundo, Not set

Ministerio da Saude Instituto Nacional do Cancer, Rio de Janeiro, Not set

SPDM - Associacao Paulista para o Desenvolvimento da Medicina - Hospital Sao Paulo, Sao Paulo, Not set

Instituto de Assistencia Medica ao Servidor Publico Estadual IAMSPE, Sao Paulo, Not set

Clinica Sao Germano, São Paulo, Not set

Fakultni nemocnice Brno, Brno, Not set

Fakultni nemocnice Hradec Kralove, Hradec Kralove, Not set

Fakultni Nemocnice Ostrava, Ostrava, Not set

Vseobecna fakultni nemocnice v Praze - I. interni klinika - klinika hematologie, Praha 2, Not set

CHU de Nantes hotel Dieu, Nantes Cedex 1, Not set

CHU de Bordeaux - Hospital Haut-Leveque, Pessac cedex, Not set

Centre hospitalier Lyon-Sud, Pierre-Bénite, Not set

CHU Bretonneau, Tours Cedex 9, Not set

CHU Nancy Brabois, Vandoeuvre Les Nancy, Not set

Klinikum Chemnitz gGmbH, Chemnitz, Not set

Universitaetsklinikum Hamburg Eppendorf, Hamburg, Not set

Asklepios Klinik Altona, Hamburg, Not set

Universitaetsklinikum Heidelberg, Heidelberg, Not set

Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II,, Tübingen, Not set

Rambam Medical Center, Haifa, Not set

Carmel Medical Center, Haifa, Not set

Hadassah Medical Center, Jerusalem, Not set

Galilee Medical Center, Nahariya, Not set

Sheba Medical Center, Ramat Gan, Not set

Tel Aviv Sourasky Medical Center, Tel-Aviv, Not set

Kanazawa University Hospital, Kanazawa, Not set

Matsuyama Red Cross Hospital, Matsuyama, Not set

Nagoya City University Hospital, Nagoya, Not set

Japanese Red Cross Medical Center, Shibuya, Not set

Inst. Cat. D'Oncologia-Badalona, Badalona, Not set

Hosp Clinic de Barcelona, Barcelona, Not set

Inst. Cat. Doncologia-H Duran I Reynals, Barcelona, Not set

Hosp Univ Vall D Hebron, Barcelona, Not set

Hosp. Gral. Univ. Gregorio Maranon, Madrid, Not set

Clinica Univ. de Navarra, Madrid, Not set

Hosp. Univ. Ramon Y Cajal, Madrid, Not set

Hosp. Univ. 12 de Octubre, Madrid, Not set

Hosp. Son Llatzer, Mallorca, Not set

Clinica Univ. de Navarra, Pamplona, Not set

Hosp Clinico Univ de Salamanca, Salamanca, Not set

Hosp. Univ. Dr. Peset, Valencia, Not set

Heart of England NHS Foundation Trust, Birmingham, Not set

Royal Bournemouth Hospital, Bournemouth, Not set

Kent and Canterbury Hospital, Canterbury, Not set

Manchester Royal Infirmary, Manchester, Not set

Derriford Hospital, Plymouth, Not set

Royal Stoke University Hospital, Stoke on Trent, Not set

Conditions: Multiple Myeloma

Learn More ›

A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT02076009

Completed

The purpose of this study is to compare the effectiveness of daratumumab when combined with lenalidomide and dexamethasone (DRd) to that of lenalidomide and dexamethasone (Rd), in terms of progression-free survival in participants with relapsed or refractory multiple myeloma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/24/2025

Locations: Not set, Little Rock, Arkansas +145 locations

Not set, Little Rock, Arkansas

Not set, Gainesville, Florida

Not set, West Palm Beach, Florida

Not set, Atlanta, Georgia

Not set, Chicago, Illinois

Not set, Iowa City, Iowa

Not set, Louisville, Kentucky

Not set, Baton Rouge, Louisiana

Not set, New Orleans, Louisiana

Not set, Bethesda, Maryland

Not set, Columbia, Maryland

Not set, Boston, Massachusetts

Not set, Rochester, Minnesota

Not set, Omaha, Nebraska

Not set, New Brunswick, New Jersey

Not set, New York, New York

Not set, Charlotte, North Carolina

Not set, Eugene, Oregon

Not set, Spartanburg, South Carolina

Not set, Austin, Texas

Not set, Dallas, Texas

Not set, Houston, Texas

Not set, Fairfax, Virginia

Not set, Camperdown, Not set

Not set, Geelong, Not set

Not set, Heidelberg, Not set

Not set, Malvern, Not set

Not set, South Brisbane, Not set

Not set, Southport, Not set

Not set, Anderlecht, Not set

Not set, Antwerpen, Not set

Not set, Edegem, Not set

Not set, Gent, Not set

Not set, Kortrijk, Not set

Not set, Leuven, Not set

Not set, Liege, Not set

Not set, Calgary, Alberta

Not set, Edmonton, Alberta

Not set, Surrey, British Columbia

Not set, Vancouver, British Columbia

Not set, Halifax, Nova Scotia

Not set, Hamilton, Ontario

Not set, London, Ontario

Not set, Toronto, Ontario

Not set, Montreal, Quebec

Not set, Quebec City, Quebec

Not set, Copenhagen, Not set

Not set, Odense, Not set

Not set, Vejle, Not set

Not set, Argenteuil, Not set

Not set, Caen, Not set

Not set, Lille, Not set

Not set, Limoges, Not set

Not set, Nantes Cedex 1, Not set

Not set, Paris, Not set

Not set, Pessac, Not set

Not set, Pierre Benite, Not set

Not set, Rennes, Not set

Not set, Toulouse Cedex 9, Not set

Not set, Tours Cedex 9, Not set

Not set, Vandoeuvre les Nancy, Not set

Not set, Berlin, Not set

Not set, Bonn, Not set

Not set, Hamburg, Not set

Not set, Hamm, Not set

Not set, Heidelberg, Not set

Not set, Jena, Not set

Not set, Karlsruhe, Not set

Not set, Koblenz, Not set

Not set, Köln, Not set

Not set, Saarbrücken, Not set

Not set, Villingen-Schwenningen, Not set

Not set, Athens Attica, Not set

Not set, Haifa, Not set

Not set, Jerusalem, Not set

Not set, Nahariya, Not set

Not set, Netanya, Not set

Not set, Petah Tikva, Not set

Not set, Ramat Gan, Not set

Not set, Tel Aviv, Not set

Not set, Hitachi, Not set

Not set, Kanazawa, Not set

Not set, Kobe, Not set

Not set, Kurume, Not set

Not set, Matsuyama, Not set

Not set, Nagoya, Not set

Not set, Narita, Not set

Not set, Ohgaki, Not set

Not set, Okayama, Not set

Not set, Osaka, Not set

Not set, Sendai-City, Not set

Not set, Shibukawa, Not set

Not set, Shibuya, Not set

Not set, Tachikawa, Not set

Not set, Tokyo, Not set

Not set, Gyeonggi-do, Not set

Not set, Incheon, Not set

Not set, Seoul, Not set

Not set, Amsterdam, Not set

Not set, Rotterdam, Not set

Not set, Utrecht, Not set

Not set, Zwolle, Not set

Not set, Brzozow, Not set

Not set, Chorzow, Not set

Not set, Gdansk, Not set

Not set, Legnica, Not set

Not set, Lublin, Not set

Not set, Poznan, Not set

Not set, Slupsk, Not set

Not set, Wroclawa, Not set

Not set, Dzerzhinsk, Not set

Not set, Ekaterinburg, Not set

Not set, Moscow, Not set

Not set, Nizhny Novgorod, Not set

Not set, Petrozavodsk, Not set

Not set, Ryazan, Not set

Not set, Samara, Not set

Not set, St-Petersburg, Not set

Not set, St. Petersburg, Not set

Not set, Syktyvkar, Not set

Not set, Badalona, Not set

Not set, Barcelona, Not set

Not set, La Laguna (Santa Cruz De Tenerife), Not set

Not set, Madrid, Not set

Not set, Pamplona, Not set

Not set, Salamanca, Not set

Not set, Sevilla, Not set

Not set, Falun, Not set

Not set, Göteborg, Not set

Not set, Helsingborg, Not set

Not set, Huddinge, Not set

Not set, Lund, Not set

Not set, Stockholm, Not set

Not set, Uppsala, Not set

Not set, Changhua, Not set

Not set, Taichung City, Not set

Not set, Tainan, Not set

Not set, Taipei, Not set

Not set, Taoyuan, Not set

Not set, Birmingham, Not set

Not set, Leeds, Not set

Not set, London, Not set

Not set, Oxford, Not set

Not set, Southampton, Not set

Not set, Surrey, Not set

Not set, Wolverhampton, Not set

Conditions: Multiple Myeloma

Learn More ›

Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma

NCT01615029

Completed

The purpose of this study is to establish the safety profile of daratumumab when given in combination with Lenalidomide and dexamethasone in participants with relapsed or relapsed and refractory Multiple Myeloma (MM).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/24/2025

Locations: Not set, Boston, Massachusetts +7 locations

Conditions: Multiple Myeloma

Learn More ›

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

NCT05372354

Recruiting

The purpose of this study is to assess the safety, tolerability and preliminary effectiveness of CC-92480 (BMS-986348) in novel therapeutic combinations for the treatment of Relapsed or Refractory Multiple Myeloma (RRMM).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/17/2025

Locations: UAB Comprehensive Cancer Center, Birmingham, Alabama +16 locations

Conditions: Multiple Myeloma

Learn More ›

Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma

NCT04484623

Active Not Recruiting

This study will evaluate the efficacy and safety of belantamab mafodotin in combination with pomalidomide and dexamethasone (Arm A) compared with that of combination of pomalidomide, bortezomib and dexamethasone (Arm B) in participants with relapsed/refractory multiple myeloma (RRMM).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/11/2025

Locations: GSK Investigational Site, Tucson, Arizona +118 locations

GSK Investigational Site, Tucson, Arizona

GSK Investigational Site, Fort Myers, Florida

GSK Investigational Site, Boston, Massachusetts

GSK Investigational Site, Kansas City, Missouri

GSK Investigational Site, Nashville, Tennessee

GSK Investigational Site, Garran, Australian Capital Territory

GSK Investigational Site, Darlinghurst, New South Wales

GSK Investigational Site, Gosford NSW, New South Wales

GSK Investigational Site, Port Macquarie, New South Wales

GSK Investigational Site, Benowa, Queensland

GSK Investigational Site, South Brisbane, Queensland

GSK Investigational Site, Adelaide, South Australia

GSK Investigational Site, Fitzroy, Victoria

GSK Investigational Site, Heidelberg, Victoria

GSK Investigational Site, Malvern, Victoria

GSK Investigational Site, Nedlands, Western Australia

GSK Investigational Site, Curitiba, Not set

GSK Investigational Site, Joinville, Not set

GSK Investigational Site, Porto Alegre, Not set

GSK Investigational Site, SAo Paulo, Not set

GSK Investigational Site, Beijing, Not set

GSK Investigational Site, Changchun, Not set

GSK Investigational Site, Changsha, Not set

GSK Investigational Site, Hangzhou, Not set

GSK Investigational Site, Jiangsu, Not set

GSK Investigational Site, Nanchang, Not set

GSK Investigational Site, Shenyang, Not set

GSK Investigational Site, Tianjin, Not set

GSK Investigational Site, Brno, Not set

GSK Investigational Site, Hradec Kralove, Not set

GSK Investigational Site, Praha 2, Not set

GSK Investigational Site, Marseille, Not set

GSK Investigational Site, Toulouse cedex 9, Not set

GSK Investigational Site, Vanduvre-lEs-Nancy, Not set

GSK Investigational Site, Mainz, Not set

GSK Investigational Site, Tuebingen, Not set

GSK Investigational Site, Wuerzburg, Not set

GSK Investigational Site, Athens, Not set

GSK Investigational Site, Ioannina, Not set

GSK Investigational Site, Thessaloniki, Not set

GSK Investigational Site, Haifa, Not set

GSK Investigational Site, Jerusalem, Not set

GSK Investigational Site, Kfar Saba, Not set

GSK Investigational Site, Nahariya, Not set

GSK Investigational Site, Petach-Tikva, Not set

GSK Investigational Site, Tel Aviv, Not set

GSK Investigational Site, Bologna, Not set

GSK Investigational Site, Milano, Not set

GSK Investigational Site, Pavia, Not set

GSK Investigational Site, Roma, Not set

GSK Investigational Site, Aichi, Not set

GSK Investigational Site, Chiba, Not set

GSK Investigational Site, Ehime, Not set

GSK Investigational Site, Fukushima, Not set

GSK Investigational Site, Gunma, Not set

GSK Investigational Site, Hokkaido, Not set

GSK Investigational Site, Iwate, Not set

GSK Investigational Site, Okayama, Not set

GSK Investigational Site, Osaka, Not set

GSK Investigational Site, Tottori, Not set

GSK Investigational Site, Yamagata, Not set

GSK Investigational Site, Gyeonggi-do, Not set

GSK Investigational Site, Hwasun, Not set

GSK Investigational Site, Inchon, Not set

GSK Investigational Site, Seoul, Not set

GSK Investigational Site, Auckland, Not set

GSK Investigational Site, Dunedin, Not set

GSK Investigational Site, Grafton, Not set

GSK Investigational Site, Hamilton, Not set

GSK Investigational Site, Takapuna Auckland, Not set

GSK Investigational Site, Tauranga, Not set

GSK Investigational Site, Bydgoszcz, Not set

GSK Investigational Site, Gdansk, Not set

GSK Investigational Site, Krakow, Not set

GSK Investigational Site, Lodz, Not set

GSK Investigational Site, Wroclaw, Not set

GSK Investigational Site, Moscow, Not set

GSK Investigational Site, Novosibirsk, Not set

GSK Investigational Site, Saint Petersburg, Not set

GSK Investigational Site, Samara, Not set

GSK Investigational Site, Sochi, Not set

GSK Investigational Site, St Petersburg, Not set

GSK Investigational Site, St-Petersburg, Not set

GSK Investigational Site, Barcelona, Not set

GSK Investigational Site, Gijon, Not set

GSK Investigational Site, L'Hospitalet De Llobrega, Not set

GSK Investigational Site, Madrid, Not set

GSK Investigational Site, MOstoles Madrid, Not set

GSK Investigational Site, Murcia, Not set

GSK Investigational Site, Palma de Mallorca, Not set

GSK Investigational Site, PamplonaNavarra, Not set

GSK Investigational Site, Pozuelo De AlarcOn Madr, Not set

GSK Investigational Site, Salamanca, Not set

GSK Investigational Site, Sevilla, Not set

GSK Investigational Site, Valencia, Not set

GSK Investigational Site, Ankara, Not set

GSK Investigational Site, Izmir, Not set

GSK Investigational Site, Kocaeli, Not set

GSK Investigational Site, Mersin, Not set

GSK Investigational Site, Samsun, Not set

GSK Investigational Site, London, Not set

GSK Investigational Site, Plymouth, Not set

GSK Investigational Site, Southampton, Not set

GSK Investigational Site, Stoke on Trent, Not set

GSK Investigational Site, Sutton, Not set

Conditions: Multiple Myeloma

Learn More ›

To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

NCT03544281

Completed

This study will evaluate the safety and tolerability profile of belantamab mafodotin when administered in combination with approved regimens of either Lenalidomide Plus Dexamethasone \[Len/Dex (Treatment A)\] or Bortezomib Plus Dexamethasone \[Bor/Dex (Treatment B)\] in participants with RRMM, i.e., those who have relapsed or who are refractory to at least 1 line of approved therapy. Participants receiving treatment A, may continue combination treatment until the occurrence of progressive disea... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

02/27/2025

Locations: GSK Investigational Site, Birmingham, Alabama +25 locations

Conditions: Multiple Myeloma

Learn More ›

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

NCT01868269

Completed

The OMS/DES study is a multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome. This trial brought on the way by specialists of the EPNS (European Paediatric Neurology Society), the GPOH (Gesellschaft für Pädiatrische Hematologic und Oncologie) and the SIOPEN (SIOP (International Society Oncology Pediatric) Europe Neuroblastoma). This protocol will investigate an escalating treatment schedule starting with a corticosteroid standard treatment with... Read More

Gender:

ALL

Ages:

Between 6 months and 8 years

Trial Updated:

01/31/2025

Locations: St. Anna Kinderkrebsforschung e.V. CHILDREN'S CANCER RESEARCH INSTITUTE, Wien, Not set +35 locations

St. Anna Kinderkrebsforschung e.V. CHILDREN'S CANCER RESEARCH INSTITUTE, Wien, Not set

Chu de Bicetre, Le Kremlin-Bicêtre, LE Kremlin Bicetre

Centre Oscar Lambret, Lille, Lille Cedex

Centre Leon Berard, Lyon, LYON Cedex 08

Hopita D'Enfants de La Timone, Marseille, Marseille Cedex 5

Hopital Arnaud de Villeneuve, Montpellier, Montpellier Cedex 4

Chr de Nantes, Nantes, Nantes Cedex01

Chu de Nice Archet 2, Nice, NICE Cedex 03

Ch Trousseau, Paris, Paris Cedex 12

Chu Hopital Sud, Rennes, Rennes Cedex 02

Chu de Rouen, Rouen, Rouen Cedex

CHU DE STRASBOURG HOPITAL Hautepierre, Strasbourg, Strasbourg Cedex

Chu Toulouse Hopital Des Enfants, Toulouse, Toulouse Cedex 9

Chu Amiens, Amiens, Not set

Chu Angers, Angers, Not set

Hopital Jean Minjoz, Besancon, Not set

Chr Pellegrin, Bordeaux, Not set

CHU CAEN, Caen, Not set

Chu D'Estaing, Clermont Ferrand, Not set

Chu Dijon, Dijon, Not set

Chu de Grenoble, Grenoble, Not set

Chu de Limoges, Limoges, Not set

Institut Curie, Paris, Not set

Chu de Poitiers, Poitiers, Not set

Chu de Reims, Reims, Not set

CHU LA REUNION Site Félix Guyon, Saint-denis, Not set

Chu Saint Etienne, Saint-Étienne, Not set

Chu Tours Hopital Clocheville, Tours, Not set

Hopital Nancy Brabois, Vandoeuvre Les Nancy, Not set

Institut de Cancerologie Gustave Roussy, Villejuif, Not set

G. Gaslini Institut, Genova, Not set

The Fundación para la Formación e Investigación Sanitarias de la Región de Murcia, El Palmar, Not set

University Hospital Lund, Lund, Not set

Universitätskinderklinik, Bern, Not set

Kinderspital Zurich, Zurich, Not set

John Radcliffe Hospital, Oxford, Not set

Conditions: Opsoclonus Myoclonus Syndrome, Neuroblastoma

Learn More ›